Benzinga | Jan 10, 2022 10:47AM EST

Cantor Fitzgerald Initiates Coverage On Bionomics with Overweight Rating, Announces Price Target of $52

Cantor Fitzgerald analyst Charles Duncan initiates coverage on Bionomics (NASDAQ:BNOX) with a Overweight rating and announces Price Target of $52.